Entry Detail



General Information

Database ID:exR0726314
RNA Name:ABLIM1
RNA Type:mRNA
Chromosome:chr10
Starnd:-
Coordinate:
Start Site(bp):114431113End Site(bp):114768061
External Links:ENSG00000099204



Disease Information

Disease Name:Bladder Cancer
Disease Category:Cancers
MeSH ID:D001749
Type:Neoplasms/Urogenital Neoplasms
Alias:Urinary Bladder Neoplasms//Neoplasm, Urinary Bladder//Urinary Bladder Neoplasm//Neoplasms, Bladder//Bladder Neoplasms//Bladder Neoplasm//Neoplasm, Bladder//Bladder Tumors//Bladder Tumor//Tumor, Bladder//Tumors, Bladder//Urinary Bladder Cancer//Cancer, Urinary Bladder//Malignant Tumor of Urinary Bladder//Cancer of the Bladder//Bladder Cancer//Bladder Cancers//Cancer, Bladder//Cancer of Bladder



Expression Detail

GEO ID:GSE51843
Description:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer
Experimental Design:Cancer vs Control
Case Disease Type:Bladder Cancer
Case Disease SubType:NA
Case Sample:Bladder Cancer
Control Sample:Control
Number of Case:5
Number of Control:6
Number of Samples:11





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CDH1
chr16
68737292
68835541
+
SMIM14
chr4
39546336
39638902
-
SLC39A7
chr6
33200445
33204439
+
COA6
chr1
234373456
234385068
+
EEF2
chr19
3976056
3985463
-
ZNF529
chr19
36534774
36605276
-
PRRC2B
chr9
131373636
131500197
+
GAPDH
chr12
6534512
6538374
+
BTBD10
chr11
13388001
13463297
-
EIF4B
chr12
53006158
53042209
+
MT-CO1
chrMT
5904
7445
+
MT-ND1
chrMT
3307
4262
+
CCNK
chr14
99481169
99535044
+
CRTAP
chr3
33114014
33147773
+
DDX47
chr12
12813316
12829981
+
HSP90AA1
chr14
102080738
102139699
-
MT-CO3
chrMT
9207
9990
+
ACTR1A
chr10
102461881
102502712
-
HLA-B
chr6
31269491
31357188
-
EIF3E
chr8
108201216
108435333
-
BTG2
chr1
203305491
203309602
+
RPS7
chr2
3575260
3580920
+
P4HB
chr17
81843161
81860624
-
GNAI3
chr1
109548615
109600195
+
TRIR
chr19
12730640
12734684
-
ANAPC11
chr17
81890790
81900991
+
WBP11
chr12
14784582
14803486
-
MRPS7
chr17
75261674
75266376
+
ALAS1
chr3
52198086
52214327
+
ZNF189
chr9
101398873
101410660
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3136-3p
chr3
69048966
69048987
-
hsa-miR-7111-3p
chr6
35470558
35470579
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
MAPKAPK5-AS1
chr12
111839764
111842902
-
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:24458310
Title:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer.
Author:Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Zorroza K,Mosen-Ansorena D, Gonzalez E, Aransay AM, Falcon-Perez JM, Unda-Urzaiz M, Royo F.
Journal:Cancers (Basel). 2014 Jan 22;6(1):179-92.
Description:LASS2 and GALNT1 were present in cancer patients, while ARHGEF39 and FOXO3 were found only in non-cancer urinary vesicles, which could be diagnostic markers for bladder cancer.